Abbott To Sell Laboratory Diagnostics Business To GE For $8.13 Billion
Wow! This has got to be one of the largest deals recently. Abbott is shedding its non-pharma units to concentrate on pharmaceuticals. The size of this deal is immense; $8.13 billion!!
Abbott will keep its Molecular Diagnostics and Diabetes Care (glucose monitoring) businesses. Not much else in any of the news I could find.
Here are the companies press releases.
• Abbott to Sell Its Core Laboratory Diagnostics Business, Including Point of Care, to GE for $8.13 Billion
• GE to Acquire Abbott’s in vitro and Point-of-Care Diagnostics Businesses for $8.13 Billion, Broadening Capabilities in Growing Global Industry
Other Resources:
Yahoo! News Search Results for abbott ge
abbott ge - Google News
Google Blog Search: abbott ge
Technorati Tags: Abbott Labs, GE, pharmaceutical deals
Related Posts:
Bookmark it with:
| 
del.icio.us
| 
Digg it
| 
Furl
| 
Simpy
| 
Spurl
| 
My Yahoo!
|
